Related Experiment Videos
Gene therapy in surgical oncology
S P Gagandeep1, G J Poston, A R Kinsella
1Department of Surgery, Royal Liverpool University Hospital, England.
Annals of Surgical Oncology
|March 1, 1995
Summary
Gene therapy introduces genetically modified cells for cancer treatment, offering potential cures beyond surgery. Future research will determine its long-term impact on patients with cancer and genetic defects.
Area of Science:
- Surgical Oncology
- Molecular Biology
- Gene Therapy
Background:
- Surgery is the primary curative treatment for many solid tumors.
- Chemotherapy and radiotherapy serve as adjuvant or palliative options.
- Recent advancements enable the clinical use of genetically modified cells.
Purpose of the Study:
- To provide surgeons with an overview of molecular biology applications.
- To highlight the potential of gene therapy in surgical oncology.
- To explain the methods of gene harnessing and insertion into somatic cells.
Main Methods:
- Utilizing modern molecular methods for stable foreign DNA transfer into somatic cells.
- Employing in situ or in vitro gene insertion into target cells.
- Introducing modified cells to physiologically relevant sites.
Main Results:
- Development of techniques for genetically modifying human somatic cells.
- Established methods for gene insertion into target cells for therapeutic purposes.
- Exploration of gene therapy's role in surgical oncology.
Conclusions:
- Initial gene therapy experiments show promise for significant clinical therapies.
- The long-term benefits for cancer and genetic defect patients remain to be determined.
- Future evidence will confirm the sufficiency of current technical skills in gene therapy.